Skip to main content
. 2018 Jun 3;32(8):e22584. doi: 10.1002/jcla.22584

Table 1.

Baseline patient characteristics and HMGB1 plasma measurements

Parameter All patients Non‐sepsis Sepsis P‐value*
Number 218 73 145
Sex (male/female) 133/85 48/25 85/60 .378
Age median (range) (y) 64 (18‐90) 61 (18‐85) 65 (20‐90) .275
APACHE‐II score median (range) 18 (2‐43) 13.5 (2‐33) 19 (4‐43) <.001
ICU days median (range) 7 (1‐137) 6 (1‐45) 9 (1‐137) .004
Death during ICU n (%) 49 (22.5%) 9 (12.3%) 40 (27.6%) .010
Death during follow‐up (total) n (%) 89 (40.8%) 22 (30.1%) 67 (46.2%) .028
Mechanical ventilation n (%) 145 (66.5%) 46 (63%) 99 (68.3%) .451
Ventilation time median (range) [h] 86 (0‐3628) 31 (0‐3628) 117 (0‐2966) .027
Pre‐existing diabetes n (%) 63 (28.9%) 22 (30.1%) 41 (28.3%) .874
BMI median (range) (m²/kg) 25.8 (14‐86) 25.7 (15.9‐40.5) 28.9 (14‐86.5) .539
WBC median (range) (×10³/μL) 13.1 (0.1‐208) 12.5 (1.8‐29.6) 14.1 (0.1‐208) .017
CRP median (range) (mg/dL) 100.5 (5‐230) 17 (5‐230) 164 (5‐230) <.001
Procalcitonin median (range) (μg/L) 0.7 (0.03‐207.5) 0.2 (0.03‐100) 2.2 (0.1‐207.5) <.001
Creatinine median (range) (mg/dL) 1.3 (0.1‐15) 1.0 (0.2‐15) 1.5 (0.1‐10.7) .013
GFR Cystatin C median (range) (mL/min) 34.5 (3‐379) 59 (5‐379) 22 (3‐218) .001
AST median (range) (U/L) 42 (7‐20 332) 47 (11‐20 332) 41 (7‐7832) .165
ALT median (range) (U/L) 30 (3‐7867) 37 (7‐7867) 25 (3‐5890) .064
Bilirubin median (range) [mg/dL] 0.7 (0.1‐20.8) 0.7 (0.1‐20.8) 0.7 (0.1‐18.9) .952
INR median (range) 1.16 (0.92‐13) 1.17 (0.95‐6.73) 1.16 (0.92‐13) .864
HMGB1 day 1 median (range) (ng/mL) 10.37 (0.20‐80) 11.21 (0.20‐76.04) 10.23 (0.20‐80) .336

ALT, alanine aminotransferase; APACHE, Acute Physiology And Chronic Health Evaluation; AST, aspartate aminotransferase; BMI, body mass index; CRP, C‐reactive protein; ICU, intensive care unit; INR, international normalized ration; HMGB1, high mobility group box 1; WBC, white blood cell.

For quantitative variables, median and range (in parenthesis) are given.*P‐values for the comparison of sepsis and non‐sepsis patients are given (U‐test for quantitative variables or chi‐square test for qualitative parameters).